4.1 Absolute mean pain (NRS 0 to 10) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
4.1.1 7 days |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
4.1.2 4 weeks |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
4.2 Participant global assessment of treatment success (Completely better/much better) |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
4.2.1 7 days |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
4.2.2 4 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
4.3 Total adverse events at 4 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
4.4 Serious adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |